مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.

Authors : Muslumanoglu M; Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Capa Fatih, Istanbul, 34090, Turkey.; Mollavelioglu B

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

Source: World journal of surgical oncology [World J Surg Oncol] 2024 Oct 31; Vol. 22 (1), pp. 286. Date of Electronic Publication: 2024 Oct 31.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy.

Authors : Cabıoğlu N; Department of Surgery, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Türkiye. .; Karanlık H

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/surgery ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

Source: World journal of surgical oncology [World J Surg Oncol] 2024 Jul 06; Vol. 22 (1), pp. 178. Date of Electronic Publication: 2024 Jul 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study.

Authors : Tang L; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Rd, Yuanjiagang, Yuzhong district, Chongqing, 400016, China.; Jiang L

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/mortality

Source: Scientific reports [Sci Rep] 2024 May 23; Vol. 14 (1), pp. 11761. Date of Electronic Publication: 2024 May 23.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis.

Authors : Niu S; Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning, 110001, China.; Sun T

Subjects: Circulating Tumor DNA*/Circulating Tumor DNA*/Circulating Tumor DNA*/blood ; Circulating Tumor DNA*/Circulating Tumor DNA*/Circulating Tumor DNA*/genetics ; Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/methods

Source: BMC cancer [BMC Cancer] 2025 Jan 22; Vol. 25 (1), pp. 115. Date of Electronic Publication: 2025 Jan 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy.

Authors : Chun JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.; Kim J

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Lymph Node Excision/Lymph Node Excision/Lymph Node Excision/*mortality

Source: Scientific reports [Sci Rep] 2021 Apr 27; Vol. 11 (1), pp. 9056. Date of Electronic Publication: 2021 Apr 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.

Authors : Wang X; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.; Wang H

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Chemotherapy, Adjuvant/Chemotherapy, Adjuvant/Chemotherapy, Adjuvant/*mortality ; Esophageal Neoplasms/Esophageal Neoplasms/Esophageal Neoplasms/*pathology

Source: BMC cancer [BMC Cancer] 2021 Feb 03; Vol. 21 (1), pp. 111. Date of Electronic Publication: 2021 Feb 03.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.

Authors : Machiels M; Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, Netherlands. .; van Montfoort ML

Subjects: Fiducial Markers*; Chemoradiotherapy, Adjuvant/Chemoradiotherapy, Adjuvant/Chemoradiotherapy, Adjuvant/*mortality ; Endoscopy/Endoscopy/Endoscopy/*methods

Source: Radiation oncology (London, England) [Radiat Oncol] 2019 Dec 04; Vol. 14 (1), pp. 219. Date of Electronic Publication: 2019 Dec 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.

Authors : Agarwal R; Department of Breast and Gynecology Oncology, Amrita Institute of Medical Sciences, Kochi, Amrita Vishwa Vidyapeedham, Kerala, India.; Philip A

Subjects: Lymph Node Ratio*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology

Source: Indian journal of cancer [Indian J Cancer] 2019 Jul-Sep; Vol. 56 (3), pp. 228-235.Publisher: Medknow Publications Country of Publication: India NLM ID: 0112040 Publication Model: Print Cited Medium: Internet ISSN: 1998-4774

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Biomarker Discordances and Alterations Observed in Breast Cancer Treated with Neoadjuvant Chemotherapy: Causes, Frequencies, and Clinical Significances.

Authors : Yilmaz C; Department of Medical Oncology, Bozyaka Training and Research Hospital, The University of Health Sciences, Izmir 35170, Turkey.; Cavdar DK

Subjects: Biomarkers, Tumor*/Biomarkers, Tumor*/Biomarkers, Tumor*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/diagnosis ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy

Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 08; Vol. 29 (12), pp. 9695-9710. Date of Electronic Publication: 2022 Dec 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Accuracy of digital mammography, ultrasound and MRI in predicting the pathological complete response and residual tumor size of breast cancer after completion of neoadjuvant chemotherapy.

Authors : Sudhir R; Department of Radiodiagnosis, Basavatarakam Indo-American Cancer Hospital and Research Centre, Hyderabad, Telangana, India.; Koppula VC

Subjects: Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/methods ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/diagnostic imaging ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

Source: Indian journal of cancer [Indian J Cancer] 2022 Jul-Sep; Vol. 59 (3), pp. 345-353.Publisher: Medknow Publications Country of Publication: India NLM ID: 0112040 Publication Model: Print Cited Medium: Internet ISSN: 1998-4774

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.

Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy.

Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study.

Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis.

Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy.

Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.

Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.

Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.

Biomarker Discordances and Alterations Observed in Breast Cancer Treated with Neoadjuvant Chemotherapy: Causes, Frequencies, and Clinical Significances.

Accuracy of digital mammography, ultrasound and MRI in predicting the pathological complete response and residual tumor size of breast cancer after completion of neoadjuvant chemotherapy.

اتصل بنا

اتبع